Review



vector pgl3  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Addgene inc vector pgl3
    Vector Pgl3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 195 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pgl3+basic+vector+luciferase+plasmid/pGL3+(-BRE)+Luciferase+(Plasmid+%2345127)/pm40876500-286-24-29
    Average 95 stars, based on 195 article reviews
    vector pgl3 - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    Clone Assay:

    Article Title: SIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
    Article Snippet: .. The MMP7 promoter region responsive to Smad4 (–438 to –379) and a larger DNA promoter fragment (–660 to –216) were cloned into pGL3-basic vector luciferase plasmid (Addgene) by using Sac1 and Xhol restriction endonucleases (New England BioLabs). .. Cells were cotransfected with MMP7 promoter-luciferase reporter and pRL-TK (Renilla luciferase; Promega) and treated with TGF-β 2 ng/ml for 48 hr.

    Plasmid Preparation:

    Article Title: SIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
    Article Snippet: .. The MMP7 promoter region responsive to Smad4 (–438 to –379) and a larger DNA promoter fragment (–660 to –216) were cloned into pGL3-basic vector luciferase plasmid (Addgene) by using Sac1 and Xhol restriction endonucleases (New England BioLabs). .. Cells were cotransfected with MMP7 promoter-luciferase reporter and pRL-TK (Renilla luciferase; Promega) and treated with TGF-β 2 ng/ml for 48 hr.

    Luciferase:

    Article Title: SIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
    Article Snippet: .. The MMP7 promoter region responsive to Smad4 (–438 to –379) and a larger DNA promoter fragment (–660 to –216) were cloned into pGL3-basic vector luciferase plasmid (Addgene) by using Sac1 and Xhol restriction endonucleases (New England BioLabs). .. Cells were cotransfected with MMP7 promoter-luciferase reporter and pRL-TK (Renilla luciferase; Promega) and treated with TGF-β 2 ng/ml for 48 hr.



    Similar Products

    95
    Addgene inc vector pgl3
    Vector Pgl3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pgl3+basic+vector+luciferase+plasmid/pGL3+(-BRE)+Luciferase+(Plasmid+%2345127)/pm40876500-286-24-29
    Average 95 stars, based on 1 article reviews
    vector pgl3 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Addgene inc pgl3 basic vector
    (a) RT-qPCR of ILF3 mRNA levels in SH-SY5Y cells overexpressing GFP-ZNF184. (b) Immunoblot analysis of ILF3 protein levels in the GFP-ZNF184-overexpressing SH-SY5Y cells. ZNF184 antibody detects both endogenous ZNF184 (indicated by a single red asterisk) and exogenous GFP-tagged ZNF184 (indicated by two red asterisks). Quantification of ILF3 protein levels is normalized to β-actin. (c) Immunoblotting of ILF3 and ZNF184 in ZNF184 knockdown SH-SY5Y cells by siRNA-ZNF184. Quantification of the immunoblot normalized to β-actin. (d) Prediction of ZNF184 consensus sequence by expanding linear SVM. (e) ChIP assay of Flag-tagged ZNF184-overexpressing SH-SY5Y cells. Rabbit IgG and histone antibodies are used as negative and positive controls, respectively. (f) Localization of ZNF184 ChIP primer binding site in the human ILF3 promoter with ZNF184 consensus sequence, human ILF3 promoter (WT) sequence, MT1 (mutant 1), MT2 (mutant 2), and MT1/2 (mutant 1 and 2) sequences. (g) Luciferase assay of overexpressing SH-SY5Y cells with <t>pGL3-basic</t> vector, pGL3-hILF3 promoter (WT), mutants (MT1, MT2, and MT1/2) and Flag- ZNF184. (h, i) Immunoblotting of ILF3 in CTX (h) and SN (i) samples of a human patient with PD ( n = 3/group). Statistical significance was assessed through a one-way ANOVA and unpaired t- test, with significance levels defined as follows: * p < 0.05, ** p < 0.01, and *** p < 0.001.
    Pgl3 Basic Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pgl3+basic+vector+luciferase+plasmid/pGL3+(-BRE)+Luciferase+(Plasmid+%2345127)/pmc12057860-102-9-11
    Average 95 stars, based on 1 article reviews
    pgl3 basic vector - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Addgene inc pgl3 luciferase basic vector
    ( A ) Schematic of the human JMJD3 gene, including gene structure, H3K27Ac, DHS, BP-associated SNPs, cloned fragments for <t>luciferase</t> assays, and vertebrate conservation (UCSC genome browser). ( B ) Luciferase results of DHS1 rs62059712 (T-major vs. C-minor) and ( C ) DHS2 rs74480102 (G-major vs. A-minor) in cultured primary human bronchial smooth muscle cells (HuBrSMCs). ( D ) qPCR for JMJD3 in HuSMCs with CRISPR/Cas9-mediated deletion of a 450 bp region encompassing rs62059712 within DHS1 (ΔDHS1) compared with unedited (WT) HuSMCs. ( E ) Sequence of rs62059712 T-major and C-minor sequences with SP1 consensus binding site underlined. ( F ) Western blot for SP1 after affinity purification using T versus C probes corresponding to rs62059712 SNP region incubated with human aortic smooth muscle cell (HuAoSMC) nuclear lysate. ( G ) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs compared with IgG negative control. ( H ) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs serum starved or treated with TGF-β. ( I ) Luciferase assays in mAoSMCs treated with siNTC and siSp1 siRNAs, then transfected with <t>pGL3-DHS1-T</t> and -C. ( J ) Luciferase assays in HuSMCs transfected with DHS1-C construct and then treated with TGF-β (20 ng/ml). ( K ) qPCR for Jmjd3 after NTC versus Sp1 knockdown in mAoSMCs serum starved for 16 hours. Data are represented as mean ± SEM. Results are representative of data from SMCs from 4–6 mice per group. n = 3 independent experiments. Two-tailed Student’s t test, * P < 0.05; ** P < 0.01.
    Pgl3 Luciferase Basic Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pgl3+basic+vector+luciferase+plasmid/pGL3+(-BRE)+Luciferase+(Plasmid+%2345127)/pmc12126237-259-6-10
    Average 95 stars, based on 1 article reviews
    pgl3 luciferase basic vector - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    93
    Addgene inc pgl3 basic luciferase vector
    ( A ) Schematic of the human JMJD3 gene, including gene structure, H3K27Ac, DHS, BP-associated SNPs, cloned fragments for <t>luciferase</t> assays, and vertebrate conservation (UCSC genome browser). ( B ) Luciferase results of DHS1 rs62059712 (T-major vs. C-minor) and ( C ) DHS2 rs74480102 (G-major vs. A-minor) in cultured primary human bronchial smooth muscle cells (HuBrSMCs). ( D ) qPCR for JMJD3 in HuSMCs with CRISPR/Cas9-mediated deletion of a 450 bp region encompassing rs62059712 within DHS1 (ΔDHS1) compared with unedited (WT) HuSMCs. ( E ) Sequence of rs62059712 T-major and C-minor sequences with SP1 consensus binding site underlined. ( F ) Western blot for SP1 after affinity purification using T versus C probes corresponding to rs62059712 SNP region incubated with human aortic smooth muscle cell (HuAoSMC) nuclear lysate. ( G ) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs compared with IgG negative control. ( H ) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs serum starved or treated with TGF-β. ( I ) Luciferase assays in mAoSMCs treated with siNTC and siSp1 siRNAs, then transfected with <t>pGL3-DHS1-T</t> and -C. ( J ) Luciferase assays in HuSMCs transfected with DHS1-C construct and then treated with TGF-β (20 ng/ml). ( K ) qPCR for Jmjd3 after NTC versus Sp1 knockdown in mAoSMCs serum starved for 16 hours. Data are represented as mean ± SEM. Results are representative of data from SMCs from 4–6 mice per group. n = 3 independent experiments. Two-tailed Student’s t test, * P < 0.05; ** P < 0.01.
    Pgl3 Basic Luciferase Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pgl3+basic+vector+luciferase+plasmid/pRF%2B275Dux4+(Plasmid+%2321293)/pm40072648-102-24-29
    Average 93 stars, based on 1 article reviews
    pgl3 basic luciferase vector - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    Promega plasmid pgl3-basic vectors carrying the firefly luciferase reporter
    ( A ) Schematic of the human JMJD3 gene, including gene structure, H3K27Ac, DHS, BP-associated SNPs, cloned fragments for <t>luciferase</t> assays, and vertebrate conservation (UCSC genome browser). ( B ) Luciferase results of DHS1 rs62059712 (T-major vs. C-minor) and ( C ) DHS2 rs74480102 (G-major vs. A-minor) in cultured primary human bronchial smooth muscle cells (HuBrSMCs). ( D ) qPCR for JMJD3 in HuSMCs with CRISPR/Cas9-mediated deletion of a 450 bp region encompassing rs62059712 within DHS1 (ΔDHS1) compared with unedited (WT) HuSMCs. ( E ) Sequence of rs62059712 T-major and C-minor sequences with SP1 consensus binding site underlined. ( F ) Western blot for SP1 after affinity purification using T versus C probes corresponding to rs62059712 SNP region incubated with human aortic smooth muscle cell (HuAoSMC) nuclear lysate. ( G ) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs compared with IgG negative control. ( H ) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs serum starved or treated with TGF-β. ( I ) Luciferase assays in mAoSMCs treated with siNTC and siSp1 siRNAs, then transfected with <t>pGL3-DHS1-T</t> and -C. ( J ) Luciferase assays in HuSMCs transfected with DHS1-C construct and then treated with TGF-β (20 ng/ml). ( K ) qPCR for Jmjd3 after NTC versus Sp1 knockdown in mAoSMCs serum starved for 16 hours. Data are represented as mean ± SEM. Results are representative of data from SMCs from 4–6 mice per group. n = 3 independent experiments. Two-tailed Student’s t test, * P < 0.05; ** P < 0.01.
    Plasmid Pgl3 Basic Vectors Carrying The Firefly Luciferase Reporter, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pgl3+basic+vector+luciferase+plasmid/pgl3+basic/10__1371_slash_journal__pbio__3002967-252-13-16
    Average 90 stars, based on 1 article reviews
    plasmid pgl3-basic vectors carrying the firefly luciferase reporter - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    93
    Addgene inc firefly luciferase gene
    Identification of HMGA2 core promoter and variation. ( A ) Relative <t>luciferase</t> activities of different lengths of promoter fragments; ( B ) Sanger sequencing detected SNP rs428001129 in NC_056056.1: 154134300-154134882 (-618 to -1200 bp upstream of the HMGA2 TSS) containing a core promoter; ( C ) rs428001129 changed HMGA2 promoter activity. P1, NC_056056.1: 154133741-154135682 (upstream of TSS, -59 to -2000 bp); P2, NC_056056.1: 154133741-154135281 (upstream of TSS, -59 to -1599 bp); P3, NC_056056.1: 154133741-154134882 (upstream of TSS, -59 to -1200 bp); P4, NC_056056.1: 154133741-154134300 (upstream of TSS, -59 to -618 bp). ** p < 0.01.
    Firefly Luciferase Gene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pgl3+basic+vector+luciferase+plasmid/pGL3+Basic+Control+Vector+(Plasmid+%23137707)/pmc11428621-195-19-26
    Average 93 stars, based on 1 article reviews
    firefly luciferase gene - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    95
    Addgene inc pgl3 basic luciferase reporter vector
    Identification of HMGA2 core promoter and variation. ( A ) Relative <t>luciferase</t> activities of different lengths of promoter fragments; ( B ) Sanger sequencing detected SNP rs428001129 in NC_056056.1: 154134300-154134882 (-618 to -1200 bp upstream of the HMGA2 TSS) containing a core promoter; ( C ) rs428001129 changed HMGA2 promoter activity. P1, NC_056056.1: 154133741-154135682 (upstream of TSS, -59 to -2000 bp); P2, NC_056056.1: 154133741-154135281 (upstream of TSS, -59 to -1599 bp); P3, NC_056056.1: 154133741-154134882 (upstream of TSS, -59 to -1200 bp); P4, NC_056056.1: 154133741-154134300 (upstream of TSS, -59 to -618 bp). ** p < 0.01.
    Pgl3 Basic Luciferase Reporter Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pgl3+basic+vector+luciferase+plasmid/pGL3+(-BRE)+Luciferase+(Plasmid+%2345127)/pm39265509-80-14-18
    Average 95 stars, based on 1 article reviews
    pgl3 basic luciferase reporter vector - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Addgene inc pgl3 luciferarase basic vector
    A) Schematic of the human JMJD3 gene including gene structure, H3K27Ac, DHS, blood pressure-associated SNPs, cloned fragments for luciferase assays, and vertebrate sequence conservation obtained from UCSC genome browser. Features were used to prioritize SNPs in transcriptionally relevant regions. B) Luciferase results of the DHS1 containing rs62059712 (T-major vs. C-minor) and C) DHS2 containing rs74480102 (G-major vs. A-minor) in cultured primary human smooth muscle cells (HuSMCs). D) qPCR for JMJD3 expression in HuSMCs with CRISPR-Cas9-mediated deletion of a 450 bp region encompassing the rs62059712 within DHS1 (ΔDHS1) compared with unedited (WT) HuSMCs. E) Sequence of the rs62059712 T-major and C-minor sequences with SP1 consensus binding site underlined. F) Western blot for SP1 after affinity purification using T vs. C probes corresponding to rs62059712 SNP region incubated with human aortic SMC (HuAoSMC) nuclear lysate. G) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs compared to IgG negative control. H) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs serum starved or treated with TGFβ. I) Luciferase assays in mAoSMCs treated with siNTC and siSp1 siRNAs then transfected with <t>pGL3-DHS1-T</t> and -C constructs. J) Luciferase assays in HuSMCs transfected with DHS1-C construct and then treated with TGFβ (20 ng/ml). K) qPCR for Jmjd3 expression after NTC vs. Sp1 knockdown in mAoSMCs. Data are presented as the mean ± SEM. Results are representative of data from SMCs from 4-6 mice per group, n=3 independent experiments. Data were first analyzed for normal distribution, and if data passed the normality test, a two-tailed Student’s t test was used, *p<0.05, **p<0.01.
    Pgl3 Luciferarase Basic Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pgl3+basic+vector+luciferase+plasmid/pGL3+(-BRE)+Luciferase+(Plasmid+%2345127)/med_rxiv__2024__07__09__24310178-69-6-10
    Average 95 stars, based on 1 article reviews
    pgl3 luciferarase basic vector - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results


    (a) RT-qPCR of ILF3 mRNA levels in SH-SY5Y cells overexpressing GFP-ZNF184. (b) Immunoblot analysis of ILF3 protein levels in the GFP-ZNF184-overexpressing SH-SY5Y cells. ZNF184 antibody detects both endogenous ZNF184 (indicated by a single red asterisk) and exogenous GFP-tagged ZNF184 (indicated by two red asterisks). Quantification of ILF3 protein levels is normalized to β-actin. (c) Immunoblotting of ILF3 and ZNF184 in ZNF184 knockdown SH-SY5Y cells by siRNA-ZNF184. Quantification of the immunoblot normalized to β-actin. (d) Prediction of ZNF184 consensus sequence by expanding linear SVM. (e) ChIP assay of Flag-tagged ZNF184-overexpressing SH-SY5Y cells. Rabbit IgG and histone antibodies are used as negative and positive controls, respectively. (f) Localization of ZNF184 ChIP primer binding site in the human ILF3 promoter with ZNF184 consensus sequence, human ILF3 promoter (WT) sequence, MT1 (mutant 1), MT2 (mutant 2), and MT1/2 (mutant 1 and 2) sequences. (g) Luciferase assay of overexpressing SH-SY5Y cells with pGL3-basic vector, pGL3-hILF3 promoter (WT), mutants (MT1, MT2, and MT1/2) and Flag- ZNF184. (h, i) Immunoblotting of ILF3 in CTX (h) and SN (i) samples of a human patient with PD ( n = 3/group). Statistical significance was assessed through a one-way ANOVA and unpaired t- test, with significance levels defined as follows: * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Journal: PLOS One

    Article Title: Zinc finger protein 184 prevents α-synuclein preformed fibril-mediated neurodegeneration through the interleukin enhancer binding factor 3-microRNA-7 pathway

    doi: 10.1371/journal.pone.0323279

    Figure Lengend Snippet: (a) RT-qPCR of ILF3 mRNA levels in SH-SY5Y cells overexpressing GFP-ZNF184. (b) Immunoblot analysis of ILF3 protein levels in the GFP-ZNF184-overexpressing SH-SY5Y cells. ZNF184 antibody detects both endogenous ZNF184 (indicated by a single red asterisk) and exogenous GFP-tagged ZNF184 (indicated by two red asterisks). Quantification of ILF3 protein levels is normalized to β-actin. (c) Immunoblotting of ILF3 and ZNF184 in ZNF184 knockdown SH-SY5Y cells by siRNA-ZNF184. Quantification of the immunoblot normalized to β-actin. (d) Prediction of ZNF184 consensus sequence by expanding linear SVM. (e) ChIP assay of Flag-tagged ZNF184-overexpressing SH-SY5Y cells. Rabbit IgG and histone antibodies are used as negative and positive controls, respectively. (f) Localization of ZNF184 ChIP primer binding site in the human ILF3 promoter with ZNF184 consensus sequence, human ILF3 promoter (WT) sequence, MT1 (mutant 1), MT2 (mutant 2), and MT1/2 (mutant 1 and 2) sequences. (g) Luciferase assay of overexpressing SH-SY5Y cells with pGL3-basic vector, pGL3-hILF3 promoter (WT), mutants (MT1, MT2, and MT1/2) and Flag- ZNF184. (h, i) Immunoblotting of ILF3 in CTX (h) and SN (i) samples of a human patient with PD ( n = 3/group). Statistical significance was assessed through a one-way ANOVA and unpaired t- test, with significance levels defined as follows: * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Article Snippet: SH-SY5Y cells were transfected for 48 h using the pGL3-basic vector (Addgene, Watertown, MA, USA), pGL3-human ILF3 promoter (pGL3-hILF3), Flag-ZNF184, pGL3-MT1, pGL3-MT2, and pGL3-MT1/2 in Opti-MEM (Gibco, Grand Island, NY, USA) with the Xtreme-gene (Roche Holding AG, Basel, Switzerland).

    Techniques: Quantitative RT-PCR, Western Blot, Knockdown, Sequencing, Binding Assay, Mutagenesis, Luciferase, Plasmid Preparation

    ( A ) Schematic of the human JMJD3 gene, including gene structure, H3K27Ac, DHS, BP-associated SNPs, cloned fragments for luciferase assays, and vertebrate conservation (UCSC genome browser). ( B ) Luciferase results of DHS1 rs62059712 (T-major vs. C-minor) and ( C ) DHS2 rs74480102 (G-major vs. A-minor) in cultured primary human bronchial smooth muscle cells (HuBrSMCs). ( D ) qPCR for JMJD3 in HuSMCs with CRISPR/Cas9-mediated deletion of a 450 bp region encompassing rs62059712 within DHS1 (ΔDHS1) compared with unedited (WT) HuSMCs. ( E ) Sequence of rs62059712 T-major and C-minor sequences with SP1 consensus binding site underlined. ( F ) Western blot for SP1 after affinity purification using T versus C probes corresponding to rs62059712 SNP region incubated with human aortic smooth muscle cell (HuAoSMC) nuclear lysate. ( G ) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs compared with IgG negative control. ( H ) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs serum starved or treated with TGF-β. ( I ) Luciferase assays in mAoSMCs treated with siNTC and siSp1 siRNAs, then transfected with pGL3-DHS1-T and -C. ( J ) Luciferase assays in HuSMCs transfected with DHS1-C construct and then treated with TGF-β (20 ng/ml). ( K ) qPCR for Jmjd3 after NTC versus Sp1 knockdown in mAoSMCs serum starved for 16 hours. Data are represented as mean ± SEM. Results are representative of data from SMCs from 4–6 mice per group. n = 3 independent experiments. Two-tailed Student’s t test, * P < 0.05; ** P < 0.01.

    Journal: The Journal of Clinical Investigation

    Article Title: Epigenetic alteration of smooth muscle cells regulates endothelin-dependent blood pressure and hypertensive arterial remodeling

    doi: 10.1172/JCI186146

    Figure Lengend Snippet: ( A ) Schematic of the human JMJD3 gene, including gene structure, H3K27Ac, DHS, BP-associated SNPs, cloned fragments for luciferase assays, and vertebrate conservation (UCSC genome browser). ( B ) Luciferase results of DHS1 rs62059712 (T-major vs. C-minor) and ( C ) DHS2 rs74480102 (G-major vs. A-minor) in cultured primary human bronchial smooth muscle cells (HuBrSMCs). ( D ) qPCR for JMJD3 in HuSMCs with CRISPR/Cas9-mediated deletion of a 450 bp region encompassing rs62059712 within DHS1 (ΔDHS1) compared with unedited (WT) HuSMCs. ( E ) Sequence of rs62059712 T-major and C-minor sequences with SP1 consensus binding site underlined. ( F ) Western blot for SP1 after affinity purification using T versus C probes corresponding to rs62059712 SNP region incubated with human aortic smooth muscle cell (HuAoSMC) nuclear lysate. ( G ) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs compared with IgG negative control. ( H ) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs serum starved or treated with TGF-β. ( I ) Luciferase assays in mAoSMCs treated with siNTC and siSp1 siRNAs, then transfected with pGL3-DHS1-T and -C. ( J ) Luciferase assays in HuSMCs transfected with DHS1-C construct and then treated with TGF-β (20 ng/ml). ( K ) qPCR for Jmjd3 after NTC versus Sp1 knockdown in mAoSMCs serum starved for 16 hours. Data are represented as mean ± SEM. Results are representative of data from SMCs from 4–6 mice per group. n = 3 independent experiments. Two-tailed Student’s t test, * P < 0.05; ** P < 0.01.

    Article Snippet: DNA fragments were then cloned into pGL3 luciferase basic vector (Addgene), and the correct sequence was verified by Sanger sequencing.

    Techniques: Clone Assay, Luciferase, Cell Culture, CRISPR, Sequencing, Binding Assay, Western Blot, Affinity Purification, Incubation, ChIP-qPCR, Negative Control, Transfection, Construct, Knockdown, Two Tailed Test

    Identification of HMGA2 core promoter and variation. ( A ) Relative luciferase activities of different lengths of promoter fragments; ( B ) Sanger sequencing detected SNP rs428001129 in NC_056056.1: 154134300-154134882 (-618 to -1200 bp upstream of the HMGA2 TSS) containing a core promoter; ( C ) rs428001129 changed HMGA2 promoter activity. P1, NC_056056.1: 154133741-154135682 (upstream of TSS, -59 to -2000 bp); P2, NC_056056.1: 154133741-154135281 (upstream of TSS, -59 to -1599 bp); P3, NC_056056.1: 154133741-154134882 (upstream of TSS, -59 to -1200 bp); P4, NC_056056.1: 154133741-154134300 (upstream of TSS, -59 to -618 bp). ** p < 0.01.

    Journal: Animals : an Open Access Journal from MDPI

    Article Title: Pleiotropic Gene HMGA2 Regulates Myoblast Proliferation and Affects Body Size of Sheep

    doi: 10.3390/ani14182721

    Figure Lengend Snippet: Identification of HMGA2 core promoter and variation. ( A ) Relative luciferase activities of different lengths of promoter fragments; ( B ) Sanger sequencing detected SNP rs428001129 in NC_056056.1: 154134300-154134882 (-618 to -1200 bp upstream of the HMGA2 TSS) containing a core promoter; ( C ) rs428001129 changed HMGA2 promoter activity. P1, NC_056056.1: 154133741-154135682 (upstream of TSS, -59 to -2000 bp); P2, NC_056056.1: 154133741-154135281 (upstream of TSS, -59 to -1599 bp); P3, NC_056056.1: 154133741-154134882 (upstream of TSS, -59 to -1200 bp); P4, NC_056056.1: 154133741-154134300 (upstream of TSS, -59 to -618 bp). ** p < 0.01.

    Article Snippet: In this study, a series of promoter deletion fragments of HMGA2 were cloned into the promoter region of the firefly luciferase gene of the pGL3-Basic vector (Addgene #212936) with the Renilla luciferase of the pRL-TK vector as an internal control.

    Techniques: Luciferase, Sequencing, Activity Assay

    A) Schematic of the human JMJD3 gene including gene structure, H3K27Ac, DHS, blood pressure-associated SNPs, cloned fragments for luciferase assays, and vertebrate sequence conservation obtained from UCSC genome browser. Features were used to prioritize SNPs in transcriptionally relevant regions. B) Luciferase results of the DHS1 containing rs62059712 (T-major vs. C-minor) and C) DHS2 containing rs74480102 (G-major vs. A-minor) in cultured primary human smooth muscle cells (HuSMCs). D) qPCR for JMJD3 expression in HuSMCs with CRISPR-Cas9-mediated deletion of a 450 bp region encompassing the rs62059712 within DHS1 (ΔDHS1) compared with unedited (WT) HuSMCs. E) Sequence of the rs62059712 T-major and C-minor sequences with SP1 consensus binding site underlined. F) Western blot for SP1 after affinity purification using T vs. C probes corresponding to rs62059712 SNP region incubated with human aortic SMC (HuAoSMC) nuclear lysate. G) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs compared to IgG negative control. H) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs serum starved or treated with TGFβ. I) Luciferase assays in mAoSMCs treated with siNTC and siSp1 siRNAs then transfected with pGL3-DHS1-T and -C constructs. J) Luciferase assays in HuSMCs transfected with DHS1-C construct and then treated with TGFβ (20 ng/ml). K) qPCR for Jmjd3 expression after NTC vs. Sp1 knockdown in mAoSMCs. Data are presented as the mean ± SEM. Results are representative of data from SMCs from 4-6 mice per group, n=3 independent experiments. Data were first analyzed for normal distribution, and if data passed the normality test, a two-tailed Student’s t test was used, *p<0.05, **p<0.01.

    Journal: medRxiv

    Article Title: Epigenetic Alteration of Smooth Muscle Cells Regulates Endothelin-Dependent Blood Pressure and Hypertensive Arterial Remodeling

    doi: 10.1101/2024.07.09.24310178

    Figure Lengend Snippet: A) Schematic of the human JMJD3 gene including gene structure, H3K27Ac, DHS, blood pressure-associated SNPs, cloned fragments for luciferase assays, and vertebrate sequence conservation obtained from UCSC genome browser. Features were used to prioritize SNPs in transcriptionally relevant regions. B) Luciferase results of the DHS1 containing rs62059712 (T-major vs. C-minor) and C) DHS2 containing rs74480102 (G-major vs. A-minor) in cultured primary human smooth muscle cells (HuSMCs). D) qPCR for JMJD3 expression in HuSMCs with CRISPR-Cas9-mediated deletion of a 450 bp region encompassing the rs62059712 within DHS1 (ΔDHS1) compared with unedited (WT) HuSMCs. E) Sequence of the rs62059712 T-major and C-minor sequences with SP1 consensus binding site underlined. F) Western blot for SP1 after affinity purification using T vs. C probes corresponding to rs62059712 SNP region incubated with human aortic SMC (HuAoSMC) nuclear lysate. G) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs compared to IgG negative control. H) ChIP-qPCR for Sp1 at the Jmjd3 promoter in mAoSMCs serum starved or treated with TGFβ. I) Luciferase assays in mAoSMCs treated with siNTC and siSp1 siRNAs then transfected with pGL3-DHS1-T and -C constructs. J) Luciferase assays in HuSMCs transfected with DHS1-C construct and then treated with TGFβ (20 ng/ml). K) qPCR for Jmjd3 expression after NTC vs. Sp1 knockdown in mAoSMCs. Data are presented as the mean ± SEM. Results are representative of data from SMCs from 4-6 mice per group, n=3 independent experiments. Data were first analyzed for normal distribution, and if data passed the normality test, a two-tailed Student’s t test was used, *p<0.05, **p<0.01.

    Article Snippet: DNA fragments were then cloned into pGL3 luciferarase basic vector (Addgene), and the correct sequence was verified by Sanger sequencing.

    Techniques: Clone Assay, Luciferase, Sequencing, Cell Culture, Expressing, CRISPR, Binding Assay, Western Blot, Affinity Purification, Incubation, ChIP-qPCR, Negative Control, Transfection, Construct, Knockdown, Two Tailed Test